The need to shed light on potential insidious SARS-CoV-2 post-vaccination pituitary lesions

Ach, Taïeb; Euch, M. El

doi:10.1016/j.therap.2022.11.012

Cited by 6 publications

(11 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…SC2V-related cerebrovascular diseases include VST, ischemic stroke, ICH, SAB, pituitary apoplexy, RCVS, cerebral vasculitis, and Susac syndrome ( Table 2 ) [ 4 , 6 …”

Section: Resultsmentioning

confidence: 99%

“…Serial MRIs revealed pituitary apoplexy that partially resolved after three months [ 41 ]. Pituitary apoplexy was also reported in a 50-year-old male who developed nausea, vomiting, diplopia, and headache 1 day after the third MOV dose [ 42 ]. The patient profited from trans-sphenoidal resection [ 42 ].…”

Section: Resultsmentioning

confidence: 99%

“…Pituitary apoplexy was also reported in a 50-year-old male who developed nausea, vomiting, diplopia, and headache 1 day after the third MOV dose [ 42 ]. The patient profited from trans-sphenoidal resection [ 42 ]. Immune-histochemical evidence for SARS-CoV-2 proteins next to pituitary capillaries was provided [ 42 ].…”

Section: Resultsmentioning

confidence: 99%

“…The patient profited from trans-sphenoidal resection [ 42 ]. Immune-histochemical evidence for SARS-CoV-2 proteins next to pituitary capillaries was provided [ 42 ]. Bleeding was explained by endothelialitis of pituitary capillaries, cross-reactivity of SARS- CoV-2 with pituitary proteins, by coagulopathy due to PF-4 antibodies, or acutely increased blood demand [ 42 ].…”

Section: Resultsmentioning

confidence: 99%

“…Immune-histochemical evidence for SARS-CoV-2 proteins next to pituitary capillaries was provided [ 42 ]. Bleeding was explained by endothelialitis of pituitary capillaries, cross-reactivity of SARS- CoV-2 with pituitary proteins, by coagulopathy due to PF-4 antibodies, or acutely increased blood demand [ 42 ]. Pituitary apoplexy 1 day after the second AZV dose was also reported in a 24-year-old female, who manifested with new, sudden-onset frontal headache that benefited from hormone substitution for pituitary insufficiency [ 43 ].…”

Section: Resultsmentioning

confidence: 99%

See 4 more Smart Citations

Neurological Adverse Reactions to SARS-CoV-2 Vaccines

Finsterer¹

2023

Clin Psychopharmacol Neurosci

View full text Add to dashboard Cite

SARS-CoV-2 vaccines are not free of side effects and most commonly affect the central or peripheral nervous system (CNS, PNS). This narrative review aims to summarise recent advances in the nature, frequency, management, and outcome of neurological side effects from SARS-CoV-2 vaccines. CNS disorders triggered by SARS-CoV-2 vaccines include headache, cerebro-vascular disorders (venous sinus thrombosis [VST], ischemic stroke, intracerebral hemorrhage, subarachnoid bleeding, reversible, cerebral vasoconstriction syndrome, vasculitis, pituitary apoplexy, Susac syndrome), inflammatory diseases (encephalitis, meningitis, demyelinating disorders, transverse myelitis), epilepsy, and a number of other rarely reported CNS conditions. PNS disorders related to SARS-CoV-2 vaccines include neuropathy of cranial nerves, mono-/polyradiculitis (Guillain-Barre syndrome [GBS]), Parsonage-Turner syndrome (plexitis), small fiber neuropathy, myasthenia, myositis/dermatomyositis, rhabdomyolysis, and a number of other conditions. The most common neurological side effects are facial palsy, intracerebral hemorrhage, VST, and GBS. The underlying pathophysiology is poorly understood, but several speculations have been generated to explain the development of CNS/PNS disease after SARS-CoV-2 vaccination. In conclusion, neurological side effects develop with any type of SARS-CoV-2 vaccine and are diverse, can be serious and even fatal, and should be taken seriously to initiate early treatment and improve outcome and avoid fatalities. KEY WORDS: Side effects; COVID-19 vaccination; Neurological; Brain; Nerves."venous sinus thrombosis", "multiple sclerosis", "acute disseminated encephalomyelitis", "seizure", "Guillain Barre syndrome", "Parsonage Turner syndrome", "myositis", and "myasthenia". In addition, reference lists were searched for additional articles that matched the search criteria. Neurological COVID Vaccination Complications 223Table 1. Most common marketed anti-SARS-CoV-2 vaccines Company Generic name Brand name Ⓡ Technology Number of dosages Biontech Pfizer BNT162b2 Comirnaty m-RNA Two/booster Moderna m-RNA1273 Spikevax m-RNA Two/booster Astra Zeneca ChAdOx1-S nCoV-19 Vaxzevira Viral vector Two/booster Curevac CVnCoV Zorecimeran m-RNA Two Novavax NVX-Cov2373 Novaxovid Protein subunit Two Johnson & Johnson Ad26.COV.2S Jcovden Viral vector One Sinovac CoronaVac CoronaVac Viral vector Two/booster Valneva VLA2001 COVID-19 vaccine Viral vector Two/booster Sinopharm COVID 2019 vaccine BIBP Viral vector Two/booster Gam-Covid-Vac Sputnik-V Gam-Covid-Vac Viral vector Two Bharat Biotech BBV152 Covaxin Viral vector Two/booster CanSino Biologics Ad5-nCoV Convidecia Viral vector Single Sinopharm BBIBP32-CorV Covilo Viral vector Two booster Sanofi Pasteur VidPrevtyn beta VidPrevtyn beta Protein subunit OneOriginal articles and reviews published between 1966 and December 2022 were included. Abstracts, proceedings, and editorials were excluded from data analysis. The review does not claim to be complete, since the number of words and references was...

show abstract

“…SC2V-related cerebrovascular diseases include VST, ischemic stroke, ICH, SAB, pituitary apoplexy, RCVS, cerebral vasculitis, and Susac syndrome ( Table 2 ) [ 4 , 6 …”

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 3 more Smart Citations

Neurological Adverse Reactions to SARS-CoV-2 Vaccines

Finsterer¹

2023

Clin Psychopharmacol Neurosci

View full text Add to dashboard Cite

show abstract

Hypophysitis in COVID-19: a systematic review

Menotti,

di Filippo,

Terenzi

et al. 2024

Pituitary

View full text Add to dashboard Cite

The Growing Understanding of the Pituitary Implication in the Pathogenesis of Long COVID-19 Syndrome: A Narrative Review

Taieb,

Nassim,

Asma

et al. 2024

ARM

View full text Add to dashboard Cite

Long COVID-19, also known as post-acute sequelae of SARS-CoV-2 infection, is a condition where individuals who have recovered from the acute phase of COVID-19 continue to experience a range of symptoms for weeks or even months afterward. While it was initially thought to primarily affect the respiratory system, it has become clear that Long COVID-19 can involve various organs and systems, including the endocrine system, which includes the pituitary gland. In the context of Long COVID-19, there is a growing understanding of the potential implications for the pituitary gland. The virus can directly affect the pituitary gland, leading to abnormalities in hormone production and regulation. This can result in symptoms such as fatigue, changes in appetite, and mood disturbances. Long COVID-19, the persistent and often debilitating condition following acute COVID-19 infection, may be explained by deficiencies in ACTH and Growth hormone production from the pituitary gland. Corticotropin insufficiency can result in the dysregulation of the body’s stress response and can lead to prolonged feelings of stress, fatigue, and mood disturbances in Long COVID-19 patients. Simultaneously, somatotropin insufficiency can affect growth, muscle function, and energy metabolism, potentially causing symptoms such as muscle weakness, exercise intolerance, and changes in body composition. Recently, some authors have suggested the involvement of the pituitary gland in Post COVID-19 Syndrome. The exact mechanisms of viral action on infected cells remain under discussion, but inflammatory and autoimmune mechanisms are primarily implicated. The aim of our study will be to review the main pituitary complications following COVID-19 infection. Moreover, we will explain the possible involvement of the pituitary gland in the persistence of Post COVID-19 Syndrome.

show abstract

The need to shed light on potential insidious SARS-CoV-2 post-vaccination pituitary lesions

Cited by 6 publications

References 4 publications

Neurological Adverse Reactions to SARS-CoV-2 Vaccines

Neurological Adverse Reactions to SARS-CoV-2 Vaccines

Hypophysitis in COVID-19: a systematic review

The Growing Understanding of the Pituitary Implication in the Pathogenesis of Long COVID-19 Syndrome: A Narrative Review

Contact Info

Product

Resources

About